Cybersecurity stock Palo Alto Networks (PANW) leads the Security-Software industry group with an IBD Composite Rating of 98 out of 99. Palo Alto crushed fiscal fourth-quarter estimates late Wednesday and sees larger deals with larger customers. Its shares have risen 44% so far this year. Let’s take a look at two other stocks in the group that are showing compelling chart action: Verisign (VRSN) and Imperva (IMPV). Verisign is working on a flat
Imperva (IMPV) stock flirted with a record high Friday after the cybersecurity firm late Thursday reported Q2 revenue that beat expectations, helped by IBM contract “takeaways.” In Q2, Imperva posted $53.5 million revenue, up 39% from the year-earlier quarter and outstripping the $48.4 million consensus of 19 analysts polled by Thomson Reuters. Services revenue accounted for 55% of total revenue, up from 35% in Q2 2014. The company attributed that
Imperva (IMPV) was initiated Monday with a buy rating and price target of 75 by Summit Research analyst Srini Nandury, who expects a secular shift to internal security measures to drive growth. “We believe Imperva has a lot of room to grow, given that it currently only has 3,900 customers worldwide, rendering its sales scope wide open,” Nandury said in a research report Monday. “Even within the supposedly hacking-aware Fortune 1000 enterprises,